SCOTTSDALE, Ariz., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced revenues of approximately $151.8 million for the three months ended September 30, 2009, compared to revenues of approximately $115.4 million for the three months ended September 30, 2008, representing an increase of approximately 31.5%. This increase was due primarily to the strength of SOLODYN(R) and the launch of DYSPORT(TM) during the quarter.
